Latest Advances

  • Condition: CASR-Associated Hypoparathyroidism
  • Journal: European journal of endocrinology
  • Treatment Used: Recombinant Human Parathyroid Hormone
  • Number of Patients: 3
  • Published —
In this study, researchers evaluated the outcomes of treating CASR-associated hypoparathyroidism with recombinant human parathyroid hormone.
  • Condition: Children with Idiopathic Hypercalciuria
  • Journal: Nutrients
  • Treatment Used: Vitamin D
  • Number of Patients: 36
  • Published —
This study analyzed the impact of Vitamin D supplementation in children with idiopathic hypercalciuria (high blood calcium).
  • Condition: Primary Hypoparathyroidism
  • Journal: The Journal of clinical endocrinology and metabolism
  • Treatment Used: Long-Term Conventional Therapy
  • Number of Patients: 165
  • Published —
This study investigated nephrocalcinosis (calcium salts in kidneys), renal dysfunction, and calculi (stones), and their predictors and progression over long-term follow-up in patients with primary hypoparathyroidism (PH) treated with long-term conventional therapy.
  • Condition: Idiopathic Hypoparathyroidism (IH)
  • Journal: The Journal of clinical endocrinology and metabolism
  • Treatment Used: Alfacalcidol and Calcium Therapy
  • Number of Patients: 92
  • Published —
This study assessed the effectiveness and safety of alfacalcidol in a large cohort of patients with idiopathic (of unknown cause) hypoparathyroidism (IH) and identified a subset who could be treated without oral calcium.
  • Condition: Chronic Hypoparathyroidism
  • Journal: European journal of endocrinology
  • Treatment Used: Vitamin D Supplements
  • Number of Patients: 170
  • Published —
This study determined complications in chronic hypoparathyroid patients treated with active vitamin D supplements.
Showing 1-5 of 5